2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments
申请人:HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
公开号:EP0545425A1
公开(公告)日:1993-06-09
The present invention relates to 2-[3-phenyl-3-(phenoxy)propyl]hydrazines of formula I
wherein R is hydrogen or loweralkyl; R₁ is hydrogen, loweralkyl, arylloweralkyl, a group of the formula
wherein R₂ is loweralkyl, or a group of the formula
wherein R₃ is hydrogen, loweralkyl, aryl, or arylloweralkyl; X and Y are hydrogen, loweralkyl, loweralkoxy, halogen, or trifluoromethyl; m and n are independently 1 or 2; the optical isomers thereof; or the pharmaceutically acceptable acid addition salts thereof, which are useful for treating personality disorders such as obsessive compulsive disorders.
This invention relates further to intermediates in and a process for the preparation of the compounds of formula I.
本发明涉及式 I 的 2-[3-苯基-3-(苯氧基)丙基]肼
其中 R 是氢或低级烷基;R₁ 是氢、低级烷基、芳基低级烷基、式中的基团
其中 R₂ 是低级烷基,或一个式基团
其中 R₃ 是氢、低级烷基、芳基或芳基低级烷基;X 和 Y 是氢、低级烷基、低级烷氧基、卤素或三氟甲基;m 和 n 独立地为 1 或 2;其光学异构体;或其药学上可接受的酸加成盐,可用于治疗强迫症等人格障碍。
本发明还涉及式 I 化合物的中间体和制备工艺。